Literature DB >> 2564966

Nafamostat to stabilise plasma samples taken for complement measurements.

J Watkins, G Wild, S Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564966     DOI： 10.1016/s0140-6736(89)92883-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Clinical utility of complement assessment.

Authors:  A E Ahmed; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

2.  C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus.

Authors:  G Wild; J Watkins; A M Ward; P Hughes; A Hume; N R Rowell
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

3.  Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Eveline Y Wu; Elizabeth A McInnis; Sonia Boyer-Suavet; Carmen E Mendoza; Lydia T Aybar; Kristin B Kennedy; Caroline J Poulton; Candace D Henderson; Yichun Hu; Susan L Hogan; Peiqi Hu; Hong Xiao; Patrick H Nachman; J Charles Jennette; Ronald J Falk; Donna O Bunch
Journal:  Arthritis Rheumatol       Date:  2019-10-08       Impact factor: 10.995

4.  A Novel Cleavage Pattern of Complement C5 Induced by Chlamydia trachomatis Infection via the Chlamydial Protease CPAF.

Authors:  Liang Peng; Jingping Gao; Zihao Hu; Hongbo Zhang; Lingli Tang; Fuyan Wang; Lei Cui; Shanshan Liu; Yujie Zhao; Hong Xu; Xin Su; Xiaojing Feng; Yiyuan Fang; Jianlin Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-11       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.